ALC saw its Momentum Indicator move above the 0 level on October 15, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 91 similar instances where the indicator turned positive. In 57 of the 91 cases, the stock moved higher in the following days. The odds of a move higher are at 63%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ALC's RSI Oscillator exited the oversold zone, 19 of 35 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 54%.
The Moving Average Convergence Divergence (MACD) for ALC just turned positive on October 09, 2026. Looking at past instances where ALC's MACD turned positive, the stock continued to rise in 31 of 54 cases over the following month. The odds of a continued upward trend are 57%.
Following a +5.68% 3-day Advance, the price is estimated to grow further. Considering data from situations where ALC advanced for three days, in 181 of 320 cases, the price rose further within the following month. The odds of a continued upward trend are 57%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The 10-day moving average for ALC crossed bearishly below the 50-day moving average on September 11, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 67%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 55%.
ALC broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ALC entered a downward trend on October 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 11 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 69 (best 1 - 100 worst), indicating slightly worse than average price growth. ALC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 70 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.481) is normal, around the industry mean (4.821). P/E Ratio (50.136) is within average values for comparable stocks, (36.081). Projected Growth (PEG Ratio) (1.165) is also within normal values, averaging (4.456). Dividend Yield (0.016) settles around the average of (0.006) among similar stocks. P/S Ratio (2.996) is also within normal values, averaging (56.074).
The Tickeron SMR rating for this company is 88 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.
The 10-day RSI Indicator for MDEV moved out of overbought territory on October 16, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 35 instances where the indicator moved out of the overbought zone. In 28 of the 35 cases the stock moved lower in the days that followed. This puts the odds of a move down at 80%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MDEV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
MDEV broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Momentum Indicator moved above the 0 level on October 09, 2026. You may want to consider a long position or call options on MDEV as a result. In 59 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 69%.
The Moving Average Convergence Divergence (MACD) for MDEV just turned positive on October 12, 2026. Looking at past instances where MDEV's MACD turned positive, the stock continued to rise in 34 of 46 cases over the following month. The odds of a continued upward trend are 74%.
MDEV moved above its 50-day moving average on October 12, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for MDEV crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 17 of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 85%.
Following a +1.35% 3-day Advance, the price is estimated to grow further. Considering data from situations where MDEV advanced for three days, in 180 of 238 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
The Aroon Indicator entered an Uptrend today. In 184 of 254 cases where MDEV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 72%.
ALC | ||
|---|---|---|
OUTLOOK RATING 1..100 | 7 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 70 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 88 | |
PRICE GROWTH RATING 1..100 | 69 | |
P/E GROWTH RATING 1..100 | 11 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| ALC | MDEV | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 54% | 3 days ago 80% |
| Stochastic ODDS (%) | 3 days ago 64% | 3 days ago 73% |
| Momentum ODDS (%) | 3 days ago 63% | 3 days ago 69% |
| MACD ODDS (%) | 3 days ago 57% | 3 days ago 74% |
| TrendWeek ODDS (%) | 3 days ago 58% | 3 days ago 72% |
| TrendMonth ODDS (%) | 3 days ago 52% | 3 days ago 69% |
| Advances ODDS (%) | 4 days ago 57% | 6 days ago 76% |
| Declines ODDS (%) | 12 days ago 55% | 11 days ago 77% |
| BollingerBands ODDS (%) | 3 days ago 55% | 3 days ago 76% |
| Aroon ODDS (%) | 3 days ago 56% | 3 days ago 72% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ALC’s FA Score shows that 1 FA rating(s) are green while .
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ALC’s TA Score shows that 4 TA indicator(s) are bullish.
ALC (@Pharmaceuticals: Other) experienced а +3.23% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.71%. For the same industry, the average monthly price growth was -3.86%, and the average quarterly price growth was +3.30%.
ALC is expected to report earnings on Nov 10, 2026.
Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
A.I.dvisor tells us that MDEV and VLTO have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MDEV and VLTO's prices will move in lockstep.
| Ticker / NAME | Correlation To MDEV | 1D Price Change % | ||
|---|---|---|---|---|
| MDEV | 100% | -0.86% | ||
| VLTO - MDEV | 14% Poorly correlated | +0.08% | ||
| STE - MDEV | 12% Poorly correlated | -0.74% | ||
| GMED - MDEV | 11% Poorly correlated | -2.70% | ||
| MDT - MDEV | 11% Poorly correlated | -0.73% | ||
| ALC - MDEV | 10% Poorly correlated | -0.60% | ||
More | ||||